LianBio is a biotechnology firm that researches and develops novel therapies for the treatment of oncology and cardiovascular diseases.
Business Model:
Revenue: $0
Employees: 51-200
Address: 1155 Fangdian Road
City: Shanghai
State: shanghai municipality
Zip: 201204
Country: CN
LianBio is a biotechnology firm that researches and develops novel therapies for the treatment of oncology and cardiovascular diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/1/2021
IPO Valuation:
$2B
Ticker Symbol:
LIAN
IPO Price:
$16/share
Amount Raised:
$325M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|